Given their role in inflammation and chronic diseases, targeting DAMPs or their signaling pathways represents a promising therapeutic strategy. Potential approaches include neutralizing antibodies against specific DAMPs, inhibitors of PRRs, and anti-inflammatory drugs. These therapies aim to mitigate the harmful effects of chronic DAMP release while preserving their beneficial roles in tissue repair.
